16 Recruiting Metastatic Castration-resistant Prostate Cancer Phase 1 Clinical Trials
Active phase 1 studies for metastatic castration-resistant prostate cancer enrolling across the USA. Verify eligibility and contact site coordinators.
All Metastatic Castration-resistant Prostate Cancer studiesPhase 1 Studies for Metastatic Castration-resistant Prostate Cancer
A Study of Copanlisib Combined With Rucaparib in Patients With Metastatic Castration-resistant Prostate Cancer
📍 Helen Diller Family Comprehensive Cancer Center University of California San Francisco — San Francisco, California
View Study & Checklist ➔ONC-392 Plus Lutetium Lu 177 Vipivotide Tetraxetan in Patients With mCRPC
📍 UC Davis Comprehensive Cancer Center — Sacramento, California
View Study & Checklist ➔A Study to Assess Adverse Events, and How Intravenously (IV) Infused ABBV-969 Moves Through the Bodies of Adult Participants With Metastatic Castration-Resistant Prostate Cancer
📍 City of Hope /ID# 262059 — Duarte, California
View Study & Checklist ➔FOR46 in Combination With Enzalutamide in Patients With Metastatic Castration Resistant Prostate Cancer
📍 University of California, San Francisco — San Francisco, California
View Study & Checklist ➔A Study to Learn How Safe the Study Treatment Actinium-225-macropa-pelgifatamab (BAY3546828) is, How it Affects the Body, How it Moves Into, Through and Out of the Body, and About Its Anticancer Activity in Participants With Advanced Metastatic Castration-resistant Prostate Cancer (mCRPC)
📍 City of Hope - Duarte Cancer Center — Duarte, California
View Study & Checklist ➔Study of Nivolumab in Combination w Radium-223 in Men w Metastatic Castration Resistant Prostate Cancer
📍 Huntsman Cancer Institute at University of Utah — Salt Lake City, Utah
View Study & Checklist ➔Chemical-Shift-Encoded MRI for Active Bone Marrow Dosimetry in Radiopharmaceutical Therapy
📍 University of Wisconsin Carbone Cancer Center — Madison, Wisconsin
View Study & Checklist ➔A Trial to Find Out if REGN4336 is Safe and How Well it Works Alone and in Combination With REGN5678 for Adult Participants With Advanced Prostate Cancer
📍 Stanford University Medical Center - Blake Wilbur Drive — Palo Alto, California
View Study & Checklist ➔Autologous Gamma Delta T Cells to Target Prostate Stem Cell Antigen in mCRPC
📍 Moffitt Cancer Center — Tampa, Florida
View Study & Checklist ➔A Study of Radiation Dosimetry, Safety, and Tolerability of Extended Lutetium (177Lu) Vipivotide Tetraxetan Treatment in Chemo-naïve Adults With Metastatic Castration-resistant Prostate Cancer: RADIOpharmaceutical DOSimetry Evaluation (RADIODOSE) Study
📍 University of California LA — Los Angeles, California
View Study & Checklist ➔A Study of Valemetostat (DS-3201b) in Combination With Darolutamide in Metastatic Castration Resistant Prostate Cancer (mCRPC)
📍 University of California San Diego Moores Cancer Center — La Jolla, California
View Study & Checklist ➔Study With [225Ac]Ac-FL-020 in mCRPC Participants
📍 City of Hope Medical Center — Duarte, California
View Study & Checklist ➔A Study to Assess BMS-986460 in Participants With Metastatic Castration-resistant Prostate Cancer
📍 Stanford Cancer Center — Palo Alto, California
View Study & Checklist ➔A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)
📍 University of California San Francisco — San Francisco, California
View Study & Checklist ➔Dose-Escalation Study of Cabozantinib in Combination With Lutetium-177 (177Lu)-PSMA-617 in Patients With Metastatic Castration-Resistant Prostate Cancer
📍 Huntsman Cancer Institute at University of Utah — Salt Lake City, Utah
View Study & Checklist ➔A Phase I Study of [225Ac]-AZD2284 in Patients With Metastatic Castration-Resistant Prostate Cancer
📍 Research Site — Palo Alto, California
View Study & Checklist ➔